Navigation Links
Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
Date:3/17/2008

duction in agitation as measured by the change from baseline in the PEC Score, measured at 2 hours after the first dose. The PEC Score is a commonly used endpoint in acute agitation studies and is the abbreviation for PANSS (Positive and Negative Symptom Scale) Excited Component Score. Various assessments of a patient's agitation state will be conducted at serial time points using standard agitation scales over the first 4-hour post-dose time period, with follow-up assessments at the end of the 24-hour study period. Side effects will be recorded throughout the 24- hour period. A second Phase 3 clinical trial is projected to begin in Q3 2008. The design of the second study will be similar to the first trial, except that the patient population will be patients with bipolar disease. AZ- 004 is being developed through Symphony Allegro, a product development partnership formed between Alexza and Symphony Capital, LLC in 2006.

-- AZ-001 (Staccato prochlorperazine) is being developed for the acute treatment of migraine headaches. Alexza reported positive results from a 400 patient Phase 2b clinical trial for this product candidate in 2007. In December 2007, Alexza completed enrollment of a thorough QT clinical trial, in which two doses of AZ-001 (5 and 10 mg) were compared to active control (moxyfloxacin) and to placebo. With more than 40 subjects per treatment arm, the Company found that the active control produced a positive QT/QTc signal that verified the sensitivity of the clinical study trial design. Based on a preliminary analysis of the data from this study, neither of the two AZ-001 doses produced a QT/QTc prolongation that Alexza believes would be suggestive of an increased risk of cardiac arrhythmia. Alexza has also initiated a 28- day inhalation toxicology study in animals and expects to complete this study in Q2 2008. Alexza intends to request an End of Phase 2 meeting for AZ-001 with the U.S. Food and Drug Administration during Q2 2008.

-- AZ-104
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
5. Spherix Reports Second Quarter Earnings
6. Tapestry Reports Second Quarter 2007 Results
7. Callisto Reports on Second-Quarter 2007 Milestones
8. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
9. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. TAXUS WOMAN Study Reports Positive Clinical Outcomes for the TAXUS(R) Drug-eluting Stent in Women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 2015 The Canadian International Pharmacy ... Canadian Anti-Fraud Centre (CAFC), continues to aggressively ... CIPA verification seal on illegitimate pharmacy websites.  The ... pharmacy member companies who have maintained a 100% ... than 10 million Americans since 2002. ...
(Date:7/28/2015)... July 28, 2015 Baebies, Inc. today announced ... $13 million. The oversubscribed round of financing included key ... Duke endowment), Cunning Capital, Triad, LLC, the Duke Angel ... Center. Many of Advanced Liquid Logic,s (ALL) former investors ... invested. "Rex is pleased to support ...
(Date:7/28/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage biopharmaceutical ... autoimmune diseases, asthma and allergic diseases, and cancer, announced ... after the market closes on Tuesday, August 4, 2015. ... the same day at 4:30 p.m. ET (1:30 p.m. ... corporate update. The live call may be ...
Breaking Medicine Technology:Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 2Canadian International Pharmacy Association (CIPA) Continues to Fight Rogues Fraudulently Using the Trusted CIPA Verification Seal 3Baebies, Inc. Raises $13 Million in Oversubscribed Round of Financing 2Xencor to Host Second Quarter 2015 Financial Results Webcast and Conference Call on August 4, 2015 2
... Spinal Association announced today the appointment of Ms. ...  Ms. Bennewith will be leading United Spinal,s legislative and ... FDA, CDC and other health-related agency concerns. ... Working from the United Spinal Washington, D.C. office, ...
... 2011 Caliper® Life Sciences, a Perkin-Elmer Company, ... an integrated solution for quantification of protein biomarkers ... Cancer Therapeutics meeting here this week.  Caliper ... and analysis solution that will deliver objective, quantitative, ...
Cached Medicine Technology:United Spinal Secures Leading Public Policy and Durable Medical Equipment Specialist: Alex Bennewith is New Director of Government Relations 2AQUA® Technology Expands to Additional Digital Pathology Platform with Launch of Vectra™ 2 from Caliper Life Sciences, a Perkin-Elmer Company 2
(Date:7/28/2015)... ... July 28, 2015 , ... Healthline , a provider ... survey (1) examining consumers’ perspectives on digital health . The survey, which ... such as innovations in digital health, level of trust in the security of digital ...
(Date:7/28/2015)... ... ... Women in Technology (WIT), the premier organization contributing to the success of professional ... Dezzutti, CEO and president at Market Connections, Inc. as the organization’s president of the ... empowers women to thrive and excel in the technology field. In order to do ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Master flutist ... inspiration taken from influences around the world, in this collection of serene, restorative instrumental ... backgrounds for sleep, for yoga practice, for body work and more -- to help ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... ... collagen-filling injectable that returns skin to a smooth state, and reduces the appearance of ... the “first and only FDA-approved injectable gel to instantly add volume to your cheek ...
(Date:7/28/2015)... Beach, FL (PRWEB) , ... July 28, 2015 , ... ... when state officials refused to schedule the hearing of proposed bills and laws revolving ... rates of new infections to date. Some vigilante ministers are continuing to hand out ...
Breaking Medicine News(10 mins):Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 4Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 2Health News:Needle Exchange Programs Are Delayed in Legislation, West Palm Beach Drug Rehab Comments 3
... Japanese study found women,who took Chlorella pyrenoidosa supplements ... their breast milk(1).,The higher levels of IgA resulted ... The study, published in the Journal of ... analyzed the breast milk in 35 Japanese women.,Eighteen ...
... HILL Psychosocial influences such as stress, depression and ... involving people infected with HIV, yet they are now ... and the spread of AIDS, according to a University ... Now, a comprehensive update on those influences in the ...
... International,Inc. (Nasdaq: DATA ), a technology and ... clinical trials industry, today announced that,it received a ... Stock Market,("Nasdaq"), notifying the Company that for the ... the bid price of the Company,s common shares ...
... new Victorian Life Sciences Computation Initiative, The University of ... supercomputing program and facility dedicated to life sciences. , ... leading computational biology facility dedicated to life sciences research ... been provided by the Victorian State Government, as announced ...
... quick and targets large tumors, sparing healthy tissue, ... -- A minimally invasive procedure normally used to treat ... according to a new study. , In ... edition of The Lancet Oncology , 88 percent ...
... Nuvelo, Inc.,(Nasdaq: NUVO ) today announced that ... officer, will present at the Jefferies 2nd Annual,Healthcare Conference ... in New,York City., A live audio webcast of ... portion of Nuvelo,s website at http://www.nuvelo.com ,or ...
Cached Medicine News:Health News:'Study Shows Mothers Who Take Chlorella Boost Babies' Antibodies During Breast Feeding' 2Health News:Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher 2Health News:Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher 3Health News:DATATRAK International, Inc. Receives Notice From Nasdaq 2Health News:DATATRAK International, Inc. Receives Notice From Nasdaq 3Health News:$100 million supercomputing program boosts Australian medical research capacity 2Health News:Non-Surgical Approach Can Treat Lung Cancers 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: